nach oben

Erschienen in:

27.06.2019 | Original Paper

Alzheimer’s disease clinical variants show distinct regional patterns of neurofibrillary tangle accumulation

verfasst von: Cathrine Petersen, Amber L. Nolan, Elisa de Paula França Resende, Zachary Miller, Alexander J. Ehrenberg, Maria Luisa Gorno-Tempini, Howard J. Rosen, Joel H. Kramer, Salvatore Spina, Gil D. Rabinovici, Bruce L. Miller, William W. Seeley, Helmut Heinsen, Lea Tenenholz Grinberg

Erschienen in: Acta Neuropathologica | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Abstract

The clinical spectrum of Alzheimer’s disease (AD) extends well beyond the classic amnestic–predominant syndrome. The previous studies have suggested differential neurofibrillary tangle (NFT) burden between amnestic and logopenic primary progressive aphasia presentations of AD. In this study, we explored the regional distribution of NFT pathology and its relationship to AD presentation across five different clinical syndromes. We assessed NFT density throughout six selected neocortical and hippocampal regions using thioflavin-S fluorescent microscopy in a well-characterized clinicopathological cohort of pure AD cases enriched for atypical clinical presentations. Subjects underwent apolipoprotein E genotyping and neuropsychological testing. Main cognitive domains (executive, visuospatial, language, and memory function) were assessed using an established composite z score. Our results showed that NFT regional burden aligns with the clinical presentation and region-specific cognitive scores. Cortical, but not hippocampal, NFT burden was higher among atypical clinical variants relative to the amnestic syndrome. In analyses of specific clinical variants, logopenic primary progressive aphasia showed higher NFT density in the superior temporal gyrus (p = 0.0091), and corticobasal syndrome showed higher NFT density in the primary motor cortex (p = 0.0205) relative to the amnestic syndrome. Higher NFT burden in the angular gyrus and CA1 sector of the hippocampus were independently associated with worsening visuospatial dysfunction. In addition, unbiased hierarchical clustering based on regional NFT densities identified three groups characterized by a low overall NFT burden, high overall burden, and cortical-predominant burden, respectively, which were found to differ in sex ratio, age, disease duration, and clinical presentation. In comparison, the typical, hippocampal sparing, and limbic-predominant subtypes derived from a previously proposed algorithm did not reproduce the same degree of clinical relevance in this sample. Overall, our results suggest domain-specific functional consequences of regional NFT accumulation. Mapping these consequences presents an opportunity to increase understanding of the neuropathological framework underlying atypical clinical manifestations.

Nur mit Berechtigung zugänglich

Ahmed S, De Jager CA, Haigh AMF, Garrard P (2012) Logopenic aphasia in Alzheimer’s disease: clinical variant or clinical feature? J Neurol Neurosurg Psychiatry 83:1056–1062. https://doi.org/10.1136/jnnp-2012-302798 CrossRefPubMed

Andrade-Moraes CH, Oliveira-Pinto AV, Castro-Fonseca E, da Silva CG, Guimaraes DM, Szczupak D et al (2013) Cell number changes in Alzheimer’s disease relate to dementia, not to plaques and tangles. Brain 136:3738–3752. https://doi.org/10.1093/brain/awt273 CrossRefPubMedPubMedCentral

Armstrong MJ, Litvan I, Lang AE, Bak TH, Bhatia KP, Borroni B et al (2013) Criteria for the diagnosis of corticobasal degeneration. Neurology 80:496–503. https://doi.org/10.1212/WNL.0b013e31827f0fd1 CrossRefPubMedPubMedCentral

Berg L, McKeel DW, Miller JP, Storandt M, Rubin EH, Morris JC et al (1998) Clinicopathologic studies in cognitively healthy aging and Alzheimer disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype. Arch Neurol 55:326–335. https://doi.org/10.1001/archneur.55.3.326 CrossRefPubMed

Brock G, Pihur V, Datta S, Datta S (2008) clValid: an R package for cluster validation. J Stat Softw 25:1–22. https://doi.org/10.18637/jss.v025.i04 CrossRef

Cairns NJ, Bigio EH, Mackenzie IRA, Neumann M, Lee VM-Y, Hatanpaa KJ et al (2007) Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol 114:5–22. https://doi.org/10.1007/s00401-007-0237-2 CrossRefPubMedPubMedCentral

Cattell RB (1966) The scree test for the number of factors. Multivariate Behav Res 1:245–276. https://doi.org/10.1207/s15327906mbr0102_10 CrossRefPubMed

Cooper DC, Klipec WD, Fowler MA, Ozkan ED (2006) A role for the subiculum in the brain motivation/reward circuitry. Behav Brain Res 174:225–231. https://doi.org/10.1016/J.BBR.2006.05.036 CrossRefPubMed

Coughlin DG, Xie SX, Liang M, Williams A, Peterson C, Weintraub D et al (2018) Cognitive and pathological influences of tau pathology in Lewy body disorders. Ann Neurol 85:259–271. https://doi.org/10.1002/ana.25392 CrossRef

10.

Crutch SJ, Lehmann M, Schott JM, Rabinovici GD, Rossor MN, Fox NC (2012) Posterior cortical atrophy. Lancet Neurol 11:170–178. https://doi.org/10.1016/S1474-4422(11)70289-7 CrossRefPubMedPubMedCentral

11.

Crutch SJ, Schott JM, Rabinovici GD, Murray M, Snowden JS, van der Flier WM et al (2017) Consensus classification of posterior cortical atrophy. Alzheimer’s Dement 13:870–884. https://doi.org/10.1016/j.jalz.2017.01.014 CrossRef

12.

Datta S, Datta S (2006) Methods for evaluating clustering algorithms for gene expression data using a reference set of functional classes. BMC Bioinform 7:397. https://doi.org/10.1186/1471-2105-7-397 CrossRef

13.

Dickson DW, Bergeron C, Chin SS, Duyckaerts C, Horoupian D, Ikeda K et al (2002) Office of rare diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol 61:935–946. https://doi.org/10.1093/jnen/61.11.935 CrossRefPubMed

14.

Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K et al (2014) Advancing research diagnostic criteria for Alzheimer’s disease: the IWG-2 criteria. Lancet Neurol 13:614–629. https://doi.org/10.1016/S1474-4422(14)70090-0 CrossRefPubMed

15.

Dunn LM, Dunn DM (2007) Peabody picture vocabulary test, PPVT-4. Eff Br mindfulness interval acute pain. Exp An Exam Individ Differ 10:10. https://doi.org/10.1017/cbo9781107415324.004 CrossRef

16.

van der Flier WM, Pijnenburg YAL, Fox NC, Scheltens P (2011) Early-onset versus late-onset Alzheimer’s disease: the case of the missing APOE ε4 allele. Lancet Neurol 10:280–288. https://doi.org/10.1016/S1474-4422(10)70306-9 CrossRefPubMed

17.

Galton CJ, Patterson K, Xuereb JH, Hodges JR (2000) Atypical and typical presentations of Alzheimer’s disease: a clinical, neuropsychological, neuroimaging and pathological study of 13 cases. Brain 123(Pt 3):484–498CrossRefPubMed

18.

Gefen T, Gasho K, Rademaker A, Lalehzari M, Weintraub S, Rogalski E et al (2012) Clinically concordant variations of Alzheimer pathology in aphasic versus amnestic dementia. Brain 135:1554–1565. https://doi.org/10.1093/brain/aws076 CrossRefPubMedPubMedCentral

19.

Gentle JE, Kaufman L, Rousseuw PJ (1991) Finding groups in data: an introduction to cluster analysis. Biometrics 47:788. https://doi.org/10.2307/2532178 CrossRef

20.

Giannakopoulos P, Herrmann FR, Bussière T, Bouras C, Kövari E, Perl DP et al (2003) Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer’s disease. Neurology 60:1495–1500. https://doi.org/10.1212/01.WNL.0000063311.58879.01 CrossRefPubMed

21.

Gorno-Tempini ML, Brambati SM, Ginex V, Ogar J, Dronkers NF, Marcone A et al (2008) The logopenic/phonological variant of primary progressive aphasia. Neurology 71:1227–1234. https://doi.org/10.1212/01.wnl.0000320506.79811.da CrossRefPubMedPubMedCentral

22.

Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, Cappa SF et al (2011) Classification of primary progressive aphasia and its variants. Neurology 76:1006–1014. https://doi.org/10.1212/WNL.0b013e31821103e6 CrossRefPubMedPubMedCentral

23.

Grijalvo-Perez AM, Litvan I (2014) Corticobasal degeneration. Semin Neurol 34:160–173. https://doi.org/10.1055/s-0034-1381734 CrossRefPubMed

24.

Hauw JJ, Daniel SE, Dickson D, Horoupian DS, Jellinger K, Lantos PL et al (1994) Preliminary NINDS neuropathologic criteria for Steele–Richardson–Olszewski syndrome (progressive supranuclear palsy). Neurology 44:2015–2019CrossRefPubMed

25.

Herman JP, Mueller NK (2006) Role of the ventral subiculum in stress integration. Behav Brain Res 174:215–224. https://doi.org/10.1016/J.BBR.2006.05.035 CrossRefPubMed

26.

Hickok G, Poeppel D (2004) Dorsal and ventral streams: a framework for understanding aspects of the functional anatomy of language. Cognition 92:67–99. https://doi.org/10.1016/j.cognition.2003.10.011 CrossRefPubMed

27.

Insausti R, Muñoz M (2001) Cortical projections of the non-entorhinal hippocampal formation in the cynomolgus monkey (Macaca fascicularis). Eur J Neurosci 14:435–451. https://doi.org/10.1046/j.0953-816X.2001.01662.x CrossRefPubMed

28.

Janocko NJ, Brodersen KA, Soto-Ortolaza AI, Ross OA, Liesinger AM, Duara R et al (2012) Neuropathologically defined subtypes of Alzheimer’s disease differ significantly from neurofibrillary tangle-predominant dementia. Acta Neuropathol 124:681–692. https://doi.org/10.1007/s00401-012-1044-y CrossRefPubMedPubMedCentral

29.

Ji J, Maren S (2008) Differential roles for hippocampal areas CA1 and CA3 in the contextual encoding and retrieval of extinguished fear. Learn Mem 15:244–251. https://doi.org/10.1101/lm.794808 CrossRefPubMedPubMedCentral

30.

Josephs KA, Dickson DW, Murray ME, Senjem ML, Parisi JE, Petersen RC et al (2013) Quantitative neurofibrillary tangle density and brain volumetric MRI analyses in Alzheimer’s disease presenting as logopenic progressive aphasia. Brain Lang 127:127–134. https://doi.org/10.1016/j.bandl.2013.02.003 CrossRefPubMed

31.

Kaiser HF (1960) The application of electronic computers to factor analysis. Educ Psychol Meas 20:141–151. https://doi.org/10.1177/001316446002000116 CrossRef

32.

Kaplan E (1983) Boston naming test. Lea & Febiger, Philadelphia

33.

Lam B, Masellis M, Freedman M, Stuss DT, Black SE (2013) Clinical, imaging, and pathological heterogeneity of the Alzheimer’s disease syndrome. Alzheimer’s Res Ther 5:1. https://doi.org/10.1186/alzrt155 CrossRef

34.

Lamy C, Duyckaerts C, Delaere P, Payan C, Fermanian J, Poulain V et al (1989) Comparison of seven staining methods for senile plaques and neurofibrillary tangles in a prospective series of 15 elderly patients. Neuropathol Appl Neurobiol 15:563–578. https://doi.org/10.1111/j.1365-2990.1989.tb01255.x CrossRefPubMed

35.

Lee SE, Rabinovici GD, Mayo MC, Wilson SM, Seeley WW, Dearmond SJ et al (2011) Clinicopathological correlations in corticobasal degeneration. Ann Neurol 70:327–340. https://doi.org/10.1002/ana.22424 CrossRefPubMedPubMedCentral

36.

Leutgeb S, Leutgeb JK, Barnes CA, Moser EI, McNaughton BL, Moser MB (2005) Neuroscience: independent codes for spatial and episodic memory in hippocampal neuronal ensembles. Science (80-) 309:619–623. https://doi.org/10.1126/science.1114037 CrossRef

37.

Mackenzie IRA, Neumann M, Baborie A, Sampathu DM, Du Plessis D, Jaros E et al (2011) A harmonized classification system for FTLD-TDP pathology. Acta Neuropathol 122:111–113. https://doi.org/10.1007/s00401-011-0845-8 CrossRefPubMedPubMedCentral

38.

Mackenzie IRA, Neumann M, Bigio EH, Cairns NJ, Alafuzoff I, Kril J et al (2010) Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update. Acta Neuropathol 119:1–4. https://doi.org/10.1007/s00401-009-0612-2 CrossRefPubMed

39.

Mattsson N, Schott JM, Hardy J, Turner MR, Zetterberg H (2016) Selective vulnerability in neurodegeneration: insights from clinical variants of Alzheimer’s disease. J Neurol Neurosurg Psychiatry 87:1000–1004. https://doi.org/10.1136/jnnp-2015-311321 CrossRefPubMed

40.

McKeith IG, Dickson DW, Lowe J, Emre M, O’Brien JT, Feldman H et al (2005) Diagnosis and management of dementia with Lewy bodies: third report of the DLB consortium. Neurology 65:1863–1872. https://doi.org/10.1212/01.wnl.0000187889.17253.b1 CrossRefPubMed

41.

McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 34:939–944CrossRefPubMed

42.

McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR, Kawas CH et al (2011) The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7:263–269. https://doi.org/10.1016/j.jalz.2011.03.005 CrossRefPubMedPubMedCentral

43.

Mesulam MM, Weintraub S, Rogalski EJ, Wieneke C, Geula C, Bigio EH (2014) Asymmetry and heterogeneity of Alzheimer’s and frontotemporal pathology in primary progressive aphasia. Brain 137:1176–1192. https://doi.org/10.1093/brain/awu024 CrossRefPubMedPubMedCentral

44.

Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW et al (2012) National institute on aging-Alzheimer’s association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach. Acta Neuropathol 123:1–11. https://doi.org/10.1007/s00401-011-0910-3 CrossRefPubMed

45.

Murray ME, Graff-Radford NR, Ross OA, Petersen RC, Duara R, Dickson DW (2011) Neuropathologically defined subtypes of Alzheimer’s disease with distinct clinical characteristics: a retrospective study. Lancet Neurol 10:785–796. https://doi.org/10.1016/S1474-4422(11)70156-9 CrossRefPubMedPubMedCentral

46.

Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S et al (1998) Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 51:1546–1554. https://doi.org/10.1212/WNL.51.6.1546 CrossRefPubMed

47.

O’Mara SM, Sanchez-Vives MV, Brotons-Mas JR, O’Hare E (2009) Roles for the subiculum in spatial information processing, memory, motivation and the temporal control of behaviour. Prog Neuro-Psychopharmacol Biol Psychiatry 33:782–790. https://doi.org/10.1016/j.pnpbp.2009.03.040 CrossRef

48.

Ohm TG, Scharnagl H, März W, Bohl J (1999) Apolipoprotein E isoforms and the development of low and high Braak stages of Alzheimer’s disease-related lesions. Acta Neuropathol 98:273–280. https://doi.org/10.1007/s004010051080 CrossRefPubMed

49.

Ossenkoppele R, Cohn-Sheehy BI, La Joie R, Vogel JW, Möller C, Lehmann M et al (2015) Atrophy patterns in early clinical stages across distinct phenotypes of Alzheimer’s disease. Hum Brain Mapp 36:4421–4437. https://doi.org/10.1002/hbm.22927 CrossRefPubMedPubMedCentral

50.

Ossenkoppele R, Mattsson N, Teunissen CE, Barkhof F, Pijnenburg Y, Scheltens P et al (2015) Cerebrospinal fluid biomarkers and cerebral atrophy in distinct clinical variants of probable Alzheimer’s disease. Neurobiol Aging 36:2340–2347. https://doi.org/10.1016/j.neurobiolaging.2015.04.011 CrossRefPubMedPubMedCentral

51.

Ossenkoppele R, Pijnenburg YAL, Perry DC, Cohn-Sheehy BI, Scheltens NME, Vogel JW et al (2015) The behavioural/dysexecutive variant of Alzheimer’s disease: clinical, neuroimaging and pathological features. Brain 138:2732–2749. https://doi.org/10.1093/brain/awv191 CrossRefPubMedPubMedCentral

52.

Ossenkoppele R, Schonhaut DR, Schöll M, Lockhart SN, Ayakta N, Baker SL et al (2016) Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer’s disease. Brain 139:1551–1567. https://doi.org/10.1093/brain/aww027 CrossRefPubMedPubMedCentral

53.

Phillips JS, Das SR, McMillan CT, Irwin DJ, Roll EE, Da Re F et al (2018) Tau PET imaging predicts cognition in atypical variants of Alzheimer’s disease. Hum Brain Mapp 39:691–708. https://doi.org/10.1002/hbm.23874 CrossRefPubMed

54.

Phillips JS, Da Re F, Dratch L, Xie SX, Irwin DJ, McMillan CT et al (2018) Neocortical origin and progression of gray matter atrophy in nonamnestic Alzheimer’s disease. Neurobiol Aging 63:75–87. https://doi.org/10.1016/j.neurobiolaging.2017.11.008 CrossRefPubMed

55.

Rabinovici GD, Furst AJ, Alkalay A, Racine CA, O’Neil JP, Janabi M et al (2010) Increased metabolic vulnerability in early-onset Alzheimer’s disease is not related to amyloid burden. Brain 133:512–528. https://doi.org/10.1093/brain/awp326 CrossRefPubMedPubMedCentral

56.

Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J et al (2011) Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 134:2456–2477. https://doi.org/10.1093/brain/awr179 CrossRefPubMedPubMedCentral

57.

Rosenbloom MH, Alkalay A, Agarwal N, Baker SL, O’Neil JP, Janabi M et al (2011) Distinct clinical and metabolic deficits in PCA and AD are not related to amyloid distribution. Neurology 76:1789–1796. https://doi.org/10.1212/WNL.0b013e31821cccad CrossRefPubMedPubMedCentral

58.

Saur D, Kreher BW, Schnell S, Kummerer D, Kellmeyer P, Vry M-S et al (2008) Ventral and dorsal pathways for language. Proc Natl Acad Sci 105:18035–18040. https://doi.org/10.1073/pnas.0805234105 CrossRefPubMedPubMedCentral

59.

Seghier ML (2013) The angular gyrus: multiple functions and multiple subdivisions. Neuroscientist 19:43–61CrossRefPubMedPubMedCentral

60.

Spinelli EG, Mandelli ML, Miller ZA, Santos-Santos MA, Wilson SM, Agosta F et al (2017) Typical and atypical pathology in primary progressive aphasia variants. Ann Neurol 81:430–443. https://doi.org/10.1002/ana.24885 CrossRefPubMedPubMedCentral

61.

Staffaroni AM, Brown JA, Casaletto KB, Elahi FM, Deng J, Neuhaus J et al (2018) The longitudinal trajectory of default mode network connectivity in healthy older adults varies as a function of age and is associated with changes in episodic memory and processing speed. J Neurosci 38:3067–4017. https://doi.org/10.1523/JNEUROSCI.3067-17.2018 CrossRef

62.

Suemoto CK, Ferretti-Rebustini REL, Rodriguez RD, Leite REP, Soterio L, Brucki SMD et al (2017) Neuropathological diagnoses and clinical correlates in older adults in Brazil: a cross-sectional study. PLoS Med 14:e1002267. https://doi.org/10.1371/journal.pmed.1002267 CrossRefPubMedPubMedCentral

63.

Suemoto CK, Leite REP, Ferretti-Rebustini REL, Rodriguez RD, Nitrini R, Pasqualucci CA, Jacob-Filho W et al (2019) Neuropathological lesions in the very old: results from a large Brazilian autopsy study. Brain Pathol. https://doi.org/10.1111/bpa.12719 CrossRefPubMedPubMedCentral

64.

Terry RD, Hansen LA, Deteresa R, Da Vies P, Tobias H, Katzman R (1987) Senile dementia of the alzheimer type without neocortical neurofibrillary tangles. J Neuropathol Exp Neurol 46:262–268. https://doi.org/10.1097/00005072-198705000-00003 CrossRefPubMed

65.

Warren JD, Fletcher PD, Golden HL (2012) The paradox of syndromic diversity in Alzheimer disease. Nat Rev Neurol 8:451–464. https://doi.org/10.1038/nrneurol.2012.135 CrossRefPubMed

Titel: Alzheimer’s disease clinical variants show distinct regional patterns of neurofibrillary tangle accumulation
verfasst von: Cathrine Petersen
Amber L. Nolan
Elisa de Paula França Resende
Zachary Miller
Alexander J. Ehrenberg
Maria Luisa Gorno-Tempini
Howard J. Rosen
Joel H. Kramer
Salvatore Spina
Gil D. Rabinovici
Bruce L. Miller
William W. Seeley
Helmut Heinsen
Lea Tenenholz Grinberg
Publikationsdatum: 27.06.2019
Verlag: Springer Berlin Heidelberg
Erschienen in: Acta Neuropathologica / Ausgabe 4/2019
Print ISSN: 0001-6322
Elektronische ISSN: 1432-0533
DOI: https://doi.org/10.1007/s00401-019-02036-6

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2019

Impact of TREM2 risk variants on brain region-specific immune activation and plaque microenvironment in Alzheimer’s disease patient brain samples

Alpha-synuclein: prion or prion-like?

Dipeptide repeat (DPR) pathology in the skeletal muscle of ALS patients with C9ORF72 repeat expansion

Calling α-synuclein a prion is scientifically justifiable

Correction to: Ketogenic diet ameliorates axonal defects and promotes myelination in Pelizaeus–Merzbacher disease